Arnason, J., Kim, W. S., Tucker, D., Ayyappan, S., Cheng, W., Tao, W., Gupta, N., Mohamed, H., Chaudhry, A., Brouwer-Visser, J. (2025). Phased variant circulating tumor DNA (ctDNA) tracking provides limited additional power in predicting progressive disease compared with duplex variant tracking in patients with Relapsed/Refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL) treated with odronextamab. Blood. https://doi.org/10.1182/blood-2025-5309